Epigenetic and transcriptomic analyses in human samples of dilated cardiomyopathy suggested that the promoter of NPPA-AS1 may act as a trans-regulatory element that is able to interact with the promoters of NPPA and NPPB and regulate their co-transcription in the diseased heart [77]. This evidence concerns the gene NPPA and dilated cardiomyopathy.